Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 17, Number 10—October 2011

Dispatch

Drug-Resistant Tuberculosis, KwaZulu-Natal, South Africa, 2001–2007

Kristina WallengrenComments to Author , Fabio Scano, Paul Nunn, Bruce Margot, Sandile S.S. Buthelezi, Brian Williams, Alexander Pym, Elisabeth Y. Samuel, Fuad Mirzayev, Wilfred Nkhoma, Lindiwe Mvusi, and Yogan Pillay
Author affiliations: KwaZulu-Natal Research Institute for Tuberculosis and HIV, University of KwaZulu-Natal, Durban, South Africa (K. Wallengren); World Health Organization, Geneva, Switzerland (F. Scano, P. Nunn, F. Mirzayev); Department of Health, Pietermaritzburg, South Africa (B. Margot, S.S.S. Buthelezi); South African Centre for Epidemiological Modelling and Analysis, Stellenbosch, South Africa (B. Williams); Medical Research Council, Durban (A. Pym); Inkosi Albert Luthuli Central Hospital, Durban (E.Y. Samuel); World Health Organization, Harare, Zimbabwe (W. Nkhoma); Department of Health, Pretoria, South Africa (L. Mvusi, Y. Pillay)

Main Article

Figure 1

Prevalence of drug-resistant tuberculosis (TB) in the 11 districts of KwaZulu-Natal, South Africa, 2001–2007. A) Multidrug-resistant (MDR) TB; B) extensively drug-resistant (XDR) TB. White bar sections, Church of Scotland Hospital; black bar sections, the rest of KwaZulu-Natal Province.

Figure 1. Prevalence of drug-resistant tuberculosis (TB) in the 11 districts of KwaZulu-Natal, South Africa, 2001–2007. A) Multidrug-resistant (MDR) TB; B) extensively drug-resistant (XDR) TB. White bar sections, Church of Scotland Hospital; black bar sections, the rest of KwaZulu-Natal Province.

Main Article

TOP